Welcome to GenPrice! Check out our latest updates.

Shopping Cart (0)

Your cart is empty

Add some products to get started!

β-Glycerophosphate (disodium salt hydrate)

β-Glycerophosphate disodium salt pentahydrate is a bioactive endogenous metabolite and a phosphatase inhibitor. β-Glycerophosphate disodium salt pentahydrate plays an important role in inducing and maintaining osteoblast differentiation, mineral metabolism and signal transduction, and can be used as a drug carrier to form heat-sensitive hydrogels. β-Glycerophosphate disodium salt hydrate accelerates the calcification of vascular smooth muscle cells[1][2][3].

Product Specifications

CAS Number

[154804-51-0]

UNSPSC

12352211

Hazard Statement

H319

Target

Endogenous Metabolite; ERK; Phosphatase

Type

Natural Products

Related Pathways

MAPK/ERK Pathway; Metabolic Enzyme/Protease; Stem Cell/Wnt

Applications

Metabolism-protein/nucleotide metabolism

Field of Research

Metabolic Disease

Assay Protocol

https://www.medchemexpress.com/glycerophosphoric-acid-disodium-salt-hydrate.html

Purity

99.85

Solubility

H2O : 175 mg/mL (ultrasonic)

Smiles

OCC(OP(O[Na])(O[Na])=O)CO.[H]O[H].[x]

Molecular Formula

C3H7O6PNa2.xH2O

Precautions

H319

References & Citations

[1]Belfield A, et al. Inhibition of the nucleotidase effect of alkaline phosphatase by beta-glycerophosphate. Nature. 1968 Jul 6;219 (5149) :73-5.|[2]Shioi A, et al. Beta-glycerophosphate accelerates calcification in cultured bovine vascular smooth muscle cells. Arterioscler Thromb Vasc Biol. 1995 Nov;15 (11) :2003-9.|[3]Langenbach F, et al. Effects of dexamethasone, ascorbic acid and β-glycerophosphate on the osteogenic differentiation of stem cells in vitro. Stem Cell Res Ther. 2013;4 (5) :117.

Shipping Conditions

Room Temperature

Storage Conditions

4°C (Powder, sealed storage, away from moisture and light)

Scientific Category

Natural Products

Clinical Information

No Development Reported

Isoform

ERK1; ERK2

Citation 01

Adv Mater. 2024 Dec 26:e2415543.|Arch Oral Biol. 2025 Aug 13:179:106374.|Biomolecules. 2025 Nov 19;15 (11) :1623.|Cell Transplant. 2025 Jan-Dec:34:9636897251376125.|Fundam Res. 2025 Jul 17.|IUBMB Life. 2024 Oct;76 (10) :832-844.|J Dent Sci. 2022 Jul;17 (3) :1281-1291.|J Pharm Anal. 2024 Oct 2.|Redox Rep. 2024 Dec;29 (1) :2428147.|Res Sq. 2025 Jul 21.|Res Sq. 2025 Oct 27.|Research Square Print. 2022 Aug.|Sci Rep. 2025 Mar 15;15 (1) :8950.|Biol Pharm Bull. 2025;48 (6) :895-907.|Biomaterials. 2024 Aug 15:313:122756.|Bone Res. 2025 Mar 3;13 (1) :30.|Free Radic Biol Med. 2025 Nov 23:243:351-366.|J Ethnopharmacol. 2024 Nov 29:340:119128.|J Mol Histol. 2021 Oct;52 (5) :1067-1080.|J Mol Histol. 2024 Aug;55 (4) :503-512.|Mater Today Bio. 2023 May 18:20:100667.|Mater Today Bio. 2025 Jun 21:33:102009.

Available Sizes

Curated Selection

Explore Other Products

Discover premium biology products from our extensive collection of 20M+ items

Rabbit Polyclonal ATG7 Antibody [CoraFluor 1]
NBP1-76650CL1 0.1 mL

Rabbit Polyclonal ATG7 Antibody [CoraFluor 1]

Ask
View Details
P2RX1 Antibody
MBS9419511-01 0.05 mL

P2RX1 Antibody

Ask
View Details
P2RX1 Antibody
MBS9419511-02 0.1 mL

P2RX1 Antibody

Ask
View Details
P2RX1 Antibody
MBS9419511-03 5x 0.1 mL

P2RX1 Antibody

Ask
View Details
TAAR1 ORF Vector (Human) (pORF)
46021011 1.0 µg DNA

TAAR1 ORF Vector (Human) (pORF)

Ask
View Details
RPS20P9 siRNA Oligos set (Human)
42244171 3x 5 nmol

RPS20P9 siRNA Oligos set (Human)

Ask
View Details